BDTX (Black Diamond) Earnings growth in current year

Official company branding of blackdiamondtherapeutics.com (BDTX)

Black Diamond (BDTX) maintains high profitability by attracting top bioinformaticians through innovative software and RSUs. The 12-month earnings per share growth rate smooths out market noise, with the metric remaining around -281.20. Monopoly income within the rare mutations niche is secured by its scientific foundation, while drug production is optimized via an external network of certified CMO partners.

BDTX (Black Diamond Therapeutics) Earnings growth in current year history from 07/04/2022 to 11/15/2026

Comprehensive metric breakdowns and analytics for Black Diamond (BDTX)

Signature product of Black Diamond Therapeutics, Inc

Black Diamond (BDTX) maintains a strong position in precision oncology, where the efficiency of developing targeted inhibitors directly impacts capitalization. The year-over-year earnings per share dynamics measure net income growth rates, reflecting a real expansion of business margins, which is clearly visualized by the annual EPS variation in the GURU.Markets analytical interface to assess the issuer's fundamental stability.

Direct competitors

GMAB: Net earnings per one share growth for the current year|EXEL (Exelixis Inc.) - Earnings growth in current year|Earnings growth in current year nuvalent.com|Earnings per share growth in current year Kymera (KYMR)|IDYA (IDEAYA Biosciences, Inc.) - Earnings per share increase in current year|Earnings growth in current year ELVN (Enliven Therapeutics Inc)|Net earnings per share change in current year ORIC Pharma|Relay Therapeutics Inc - Earnings growth in current year|Earnings per share growth rate in current year Nurix Therapeutics, Inc.|TYRA (Tyra Biosciences, Inc.) - Net earnings per share growth this year|VSTM: Net earnings per one share growth for the current year|GLUE (monterosatx.com) - Earnings growth in current year|Earnings per share growth rate in current year Cullinan Therapeutics Inc CGEM|Earnings growth in current year IMRX|C4 Therapeutics - Earnings per share growth this year|Repare Therapeutics Inc. - Net earnings per share growth this year|Earnings per share increase in current year PMVP|KPTI: Net earnings per share growth this year|propanc.com - Net earnings per one share growth for the current year|BGMS: Earnings growth in current year|Aadi Bioscience Inc - Earnings per share increase in current year|ALRN (Aileron Therapeutics Inc) - Earnings growth in current year|Earnings per share growth rate in current year blueprintmedicines.com BPMC|Earnings per share growth in current year GlycoMimetics Inc. (GLYC)|SWTX (SpringWorks) - Earnings per share increase in current year